Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: S01EC02

Ekesivy(diclofenamide)

Paralyses, Familial Periodic

Marketing Authorisation Holder: Sun Pharmaceutical Industries Europe B.V.

Indication

Treatment of periodic paralysis.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ekesivy — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.